12/13/2024
3:13 PM | Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:20 PM | Alnylam Pharmaceuticals (Issuer)
Fitzgerald Kevin Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:21 PM | Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:21 PM | Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:22 PM | Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:22 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:06 PM | Alnylam Pharmaceuticals (Subject)
Fitzgerald Kevin Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/08/2024
9:34 AM | Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
10/31/2024
7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
7:22 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/03/2024
3:11 PM | Alnylam Pharmaceuticals (Issuer)
Hesslein Robert W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:01 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
4:10 PM | Alnylam Pharmaceuticals (Subject)
Greenstreet Yvonne (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
8:40 AM | Alnylam Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
08/02/2024
7:01 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
7:22 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
7:11 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
7:02 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:40 PM | Alnylam Pharmaceuticals (Subject)
Greenstreet Yvonne (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2024
9:24 AM | Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
05/31/2024
6:00 PM | Alnylam Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:34 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
7:21 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
7:11 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:37 PM | Alnylam Pharmaceuticals (Filer)
| Form ARS | |
04/01/2024
3:31 PM | Alnylam Pharmaceuticals (Filer)
| Form DEF 14A | |
03/04/2024
3:33 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:16 PM | Alnylam Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:17 PM | Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:18 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:18 PM | Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:18 PM | Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:00 PM | Alnylam Pharmaceuticals (Subject)
SHARP PHILLIP A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
7:35 AM | Alnylam Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
7:40 AM | Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/05/2024
3:05 PM | Alnylam Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
11:18 AM | Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
01/19/2024
3:31 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:00 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
